Covid: Oxford-AstraZeneca vaccine to be tested on childrenon February 13, 2021 at 1:15 pm

A trial will assess whether the vaccine produces a strong immune response in six to 17-year-olds.

“There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults.”